NOVO.B.DK

254.6

+2.87%↑

GMAB.DK

1,728.5

-0.17%↓

HLUNB.DK

38.06

+1.44%↑

ZEAL.DK

253.3

+7.74%↑

AMBUB.DK

74.55

-1.58%↓

NOVO.B.DK

254.6

+2.87%↑

GMAB.DK

1,728.5

-0.17%↓

HLUNB.DK

38.06

+1.44%↑

ZEAL.DK

253.3

+7.74%↑

AMBUB.DK

74.55

-1.58%↓

NOVO.B.DK

254.6

+2.87%↑

GMAB.DK

1,728.5

-0.17%↓

HLUNB.DK

38.06

+1.44%↑

ZEAL.DK

253.3

+7.74%↑

AMBUB.DK

74.55

-1.58%↓

NOVO.B.DK

254.6

+2.87%↑

GMAB.DK

1,728.5

-0.17%↓

HLUNB.DK

38.06

+1.44%↑

ZEAL.DK

253.3

+7.74%↑

AMBUB.DK

74.55

-1.58%↓

NOVO.B.DK

254.6

+2.87%↑

GMAB.DK

1,728.5

-0.17%↓

HLUNB.DK

38.06

+1.44%↑

ZEAL.DK

253.3

+7.74%↑

AMBUB.DK

74.55

-1.58%↓

Search

Coloplast A-S (Class B)

Suletud

451.7 -2.36

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

450.5

Max

460.7

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

27.175

66.845

Aktsiakasum

6.32

Dividenditootlus

4.74

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.74%

2.25%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-10B

108B

Eelmine avamishind

454.06

Eelmine sulgemishind

451.7

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. märts 2026, 19:32 UTC

Omandamised, ülevõtmised, äriostud

Diana Shipping Increases Offer to Acquire Genco -- Update

8. märts 2026, 23:47 UTC

Market Talk
Uudisväärsed sündmused

Global Equities Roundup: Market Talk

8. märts 2026, 23:47 UTC

Market Talk
Uudisväärsed sündmused

Nikkei May Fall on Higher Energy Prices, Signs of U.S. Econ Weakness -- Market Talk

8. märts 2026, 23:46 UTC

Market Talk
Uudisväärsed sündmused

Gold Falls Amid Dollar's Strength -- Market Talk

8. märts 2026, 23:34 UTC

Market Talk
Uudisväärsed sündmused

Oil Futures Surge Above $100/bbl Amid Growing Middle East Conflict -- Market Talk

8. märts 2026, 23:08 UTC

Uudisväärsed sündmused

Front-month WTI Crude Futures Jump 16.6%, Front-Month Brent Crude Futures Climb 15.2%

8. märts 2026, 23:05 UTC

Uudisväärsed sündmused

Front-month Crude Oil Futures Surge Amid Rising Middle East Conflict

8. märts 2026, 22:37 UTC

Uudisväärsed sündmused

The Long-Feared Persian Gulf Oil Squeeze Is Upon -2-

8. märts 2026, 22:37 UTC

Uudisväärsed sündmused

The Long-Feared Persian Gulf Oil Squeeze Is Upon Us -- WSJ

7. märts 2026, 02:30 UTC

Uudisväärsed sündmused

Iran War Is Kicking India When It's Already Down -- Barrons.com

6. märts 2026, 22:26 UTC

Uudisväärsed sündmused

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

6. märts 2026, 22:07 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

6. märts 2026, 22:03 UTC

Market Talk

Global Equities Roundup: Market Talk

6. märts 2026, 22:03 UTC

Market Talk

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

6. märts 2026, 21:50 UTC

Market Talk
Uudisväärsed sündmused

Financial Services Roundup: Market Talk

6. märts 2026, 21:37 UTC

Tulu

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

6. märts 2026, 21:25 UTC

Uudisväärsed sündmused

How The Iran War Impacts Ukraine. -- Barrons.com

6. märts 2026, 21:17 UTC

Tulu

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

6. märts 2026, 20:50 UTC

Tulu

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

6. märts 2026, 20:46 UTC

Tulu

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

6. märts 2026, 20:31 UTC

Uudisväärsed sündmused

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

6. märts 2026, 20:18 UTC

Market Talk

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

6. märts 2026, 20:12 UTC

Market Talk
Uudisväärsed sündmused

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

6. märts 2026, 19:10 UTC

Market Talk
Uudisväärsed sündmused

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

6. märts 2026, 18:54 UTC

Market Talk

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

6. märts 2026, 18:44 UTC

Market Talk
Uudisväärsed sündmused

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

6. märts 2026, 18:08 UTC

Tulu

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6. märts 2026, 18:04 UTC

Tulu

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6. märts 2026, 18:04 UTC

Tulu

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6. märts 2026, 17:49 UTC

Market Talk

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat